Table 2.

Antioxidant defense system in the liver of Sprague Dawley rats with hepatotoxicity induced by CCl₄ treated with Tamarindus indica L. tablets.

Group	MDA	SOD	CAT	GSH
	(nmol/g tissue)	(UI/mg tissue)	(UI/mg tissue)	(mg/g tissue)
I	0.47 ± 0.04c	0.35 ± 0.02a	0.40 ± 0.02a.b	29.74 ± 1.98b
II	1.49 ± 0.18a	0.15 ± 0.01d	0.13 ± 0.02d	15.84 ± 1.30c
III	0.66 ± 0.03b	0.31 ± 0.02b.c	0.36 ± 0.02c	32.58 ± 2.68a.b
IV	0.60 ± 0.04b.c	0.28 ± 0.03c	0.43 ± 0.02a	33.01 ± 2.26a
V	0.64 ± 0.03b	0.33 ± 0.02a.b	0.37 ± 0.03b.c	29.93 ± 0.90b

MDA: malondialdehyde; SOD: superoxide dismutase; CAT: catalase; GSH: reduced glutathione.

I: control group; II: CCl₄ induced hepatotoxicity group; III: Silymarin treated group; IV and V: Tamarindus indica L. tablets treated groups at doses 100 mg/kg and 200 mg/kg, respectively.

Data are expressed as mean ± SD (n = 7).

Different letters on columns indicate significant statistical differences (p < 0.05).